Development and Characterization of Naproxen-Loaded Solid Lipid Nanoparticles for Chronotherapeutic Applications
International Journal of Drug Delivery Technology · 19.05.2026 · 16 (30s)
DOI: 10.25258/ijddt.16.30s.85 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 19.05.2026. Verfasst von Sharad S. Kharat und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
The study aimed to develop and optimize Naproxen-loaded solid lipid nanoparticles (NAP-SLNs) using high-pressure homogenization to enhance solubility, achieve sustained drug release, and improve overall therapeutic efficacy.
Methods
A full factorial 2³ design was employed to optimize formulation variables including lipid concentration, surfactant concentration, and homogenization cycles. Compritol ATO 888 and Poloxamer 188 were used as lipid and surfactant, respectively. The prepared SLNs were characterized for particle size, polydispersity index (PDI), zeta potential, and encapsulation efficiency (% EE). In-vitro drug release studies were conducted in phosphate buffer (pH 6.8) using a USP Type II dissolution apparatus. The optimized batch was further evaluated for stability under ICHrecommended conditions.
Results
The optimized formulation (F7) exhibited desirable physicochemical properties with a particle size of 134.5 nm, PDI of 0.351, and %EE of 89.67%. The drug release profile showed a biphasic pattern with an initial burst followed by sustained release up to 24 hours, releasing 76.02% of Naproxen. Stability studies indicated good physical and chemical stability under refrigerated conditions.
Conclusion
The developed NAP-SLNs effectively sustained drug release and demonstrated enhanced stability, making them a promising nanocarrier system for improving the oral delivery of Naproxen. This formulation could reduce dosing frequency and associated gastrointestinal side effects, contributing to better patient compliance.
Zitieren
APA
Kharat, S. S., & Patil, M. P. (2026). Development and Characterization of Naproxen-Loaded Solid Lipid Nanoparticles for Chronotherapeutic Applications. International Journal of Drug Delivery Technology, 16(30s). https://doi.org/10.25258/ijddt.16.30s.85
Vancouver
Kharat SS, Patil MP. Development and Characterization of Naproxen-Loaded Solid Lipid Nanoparticles for Chronotherapeutic Applications. International Journal of Drug Delivery Technology. 2026;16(30s). doi:10.25258/ijddt.16.30s.85
BibTeX
@article{Kharat2026,
author = {Kharat, Sharad S. and Patil, Moreshwar P.},
title = {Development and Characterization of Naproxen-Loaded Solid Lipid Nanoparticles for Chronotherapeutic Applications},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {30s},
doi = {10.25258/ijddt.16.30s.85}
}
EUVIMED